UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.
UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
プロテアソーム阻害剤であるMG132は、ユビキチン-プロテアソーム経路に影響を与え、UBE2Uの機能に影響を与える可能性がある。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
もう一つのプロテアソーム阻害剤であるボルテゾミブは、タンパク質分解経路に影響を与えることで、間接的にUBE2Uに影響を与える可能性がある。 | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
プロテアソームの特異的阻害剤であるラクタシスチンは、ユビキチン化プロセスを調節し、UBE2Uに影響を与える可能性がある。 | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
ユビキチン活性化酵素E1の阻害剤であるPYR-41は、ユビキチン化経路におけるUBE2Uの活性に間接的に影響を与える可能性がある。 | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
脱ユビキチン化酵素であるUSP14を阻害し、UBE2Uが関与するユビキチン化経路に影響を及ぼす可能性がある。 | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
タンパク質分解経路を調節し、UBE2Uの活性に間接的な影響を与える可能性がある。 | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
免疫調節薬は、タンパク質のホメオスタシスに影響を与え、UBE2Uの機能にも影響を与える可能性がある。 | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $98.00 $140.00 $306.00 $459.00 $1224.00 $1958.00 | 1 | |
サリドマイドと同様、タンパク質分解経路に影響を与え、UBE2Uに影響を与える可能性がある。 |